This is why the Shine Corporate Ltd share price dropped 1.5% today

Shares of law firm, Shine Corporate Ltd (ASX:SHJ), have fallen despite announcing a promising acquisition in the West Australian personal injury market.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of Australian law firm, Shine Corporate Ltd (ASX: SHJ), today trended as much as 1.56% lower, on the back of an update this morning.

In a statement to the ASX, Shine said it has entered into an agreement to acquire West Australian law firm, Bradley Bayly, a specialist in personal injury and large catastrophic injuries.

The deal is expected to be completed by August 14 and will cost $13.275 million. It'll be mostly funded by debt, with just a $1 million scrip offer (i.e. shares in Shine Corporate). The deal is expected to be earnings per share (EPS) accretive in its 2016 financial year.

"Post completion of this transaction, Shine will have a stronger presence in Western Australia in the PI areas with our Stephen Browne business," Shine's Managing Director, Simon Morrison, said. "In addition to meeting our strategic acquisition criteria, the firm has similar cultures and values and will contribute to Shine's future earnings growth as synergies are realised."

Is it time to buy Shine Corporate shares?

After a declining share price in 2015 (it was down 22% in the first six months of this year), Shine's share price has jumped 12.4% over the past five days – up until today. Make of that what you will.

Following the fall of Slater & Gordon Limited's (ASX: SGH) share price throughout 2015, it's possible investors had become concerned about the strategies employed by law firms seeking to 'roll up' the industry by buying smaller rivals.

However, personally, I think Shine has done a good job of acquiring businesses to date, and likely deserves a spot on your watchlist.

Motley Fool contributor Owen Raskiewicz owns shares of Slater & Gordon. Owen welcomes your feedback on Google+ (see below), LinkedIn or you can follow him on Twitter @ASXinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »